Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cinacalcet (60mg) Tablet
Therapeutic Category
Nephrology, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cinaclat 60 Tablet contains Cinacalcet 60 mg, a potent calcimimetic agent indicated for secondary hyperparathyroidism in chronic kidney disease (CKD) patients on dialysis and parathyroid carcinoma. It works by enhancing the sensitivity of calcium-sensing receptors on parathyroid glands, reducing PTH secretion, and effectively controlling serum calcium levels.
This higher-dose formulation is particularly useful for patients with persistent elevated PTH or hypercalcemia who require stronger control. Cinacalcet helps prevent bone disease, vascular calcification, and associated metabolic complications in CKD.
Clinically, Cinaclat 60 Tablet is indicated for secondary hyperparathyroidism, parathyroid carcinoma, and metabolic calcium-phosphate disorders, providing reliable therapeutic outcomes and improved patient management.
The tablet ensures precise dosing, convenient oral administration, and consistent clinical effect, making it suitable for hospital, dialysis, and long-term outpatient care.
Common side effects may include nausea, vomiting, hypocalcemia, dizziness, and headache. Rarely, severe hypocalcemia, muscle cramps, or allergic reactions may occur.
Cinaclat 60 Tablet contains Cinacalcet 60 mg, a potent calcimimetic agent indicated for secondary hyperparathyroidism in chronic kidney disease (CKD) patients on dialysis and parathyroid carcinoma. It works by enhancing the sensitivity of calcium-sensing receptors on parathyroid glands, reducing PTH secretion, and effectively controlling serum calcium levels. This higher-dose formulation is particularly useful for patients with persistent elevated PTH or hypercalcemia who require stronger control. Cinacalcet helps prevent bone disease, vascular calcification, and associated metabolic complications in CKD. Clinically, Cinaclat 60 Tablet is indicated for secondary hyperparathyroidism, parathyroid carcinoma, and metabolic calcium-phosphate disorders, providing reliable therapeutic outcomes and improved patient management. The tablet ensures precise dosing, convenient oral administration, and consistent clinical effect, making it suitable for hospital, dialysis, and long-term outpatient care.
Use Cinaclat 60 Tablet strictly under medical supervision. Regular monitoring of serum calcium, phosphate, and PTH levels is essential. Inform your doctor of any history of hypocalcemia, cardiac arrhythmias, or gastrointestinal disorders. Seek immediate medical attention if severe muscle cramps, numbness, or irregular heartbeat develops.
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children. Do not use beyond the expiry date.
Composition : Calcium Carbonate (1250mg) + Vitamin D3 (2000IU) + Methylcobalamin (1500mcg) + L-Methyl Folate Calcium (1mg) + Pyridoxal-5-phosphate (0.5mg)
Composition : Calcium Carbonate (1250mg) + Vitamin D3 (250 IU)
Composition : Calcium Citrate U.S.P. 1000mg + Magnesium Hydroxide I.P. 100mg + Zinc Sulphate 4mg + Vitamin D3 I.P. 200 IU
Composition : Calcium Citrate 750mg + Calcium Aspartate Anhydrous 500mg + Calcium Orotate 100mg + Vitamin D3 500 IU Tablets
Composition : Calcium Citrate Malate (250mg) + Vitamin D3 (100mg) + Folic Acid (50mcg) Tablet
Composition : Cissus quadrangularis (500mg), Calcium citrate malate (500mg), Calcitriol, Vitamin K2-7 (0.25mcg), Methylcobalamin, Folic acid and Zinc (300mcg) Tablet
Composition : Coenzyme Q10 100mg + DHA 10% 90mg + Melatonin 2mg + Chromium Picolinate 200mcg + N-acetyl L-cysteine 50mg + L-arginine 25mg + Zinc 15mg + Folic Acid 176.46mcg + Selenium 40mcg + Iodine 50mcg + Vitamin C 40mg + Vitamin A 1000 IU + Vitamin D3 400 IU + Vitamin B12 1mcg
Composition : Co-enzyme Q10 60mg + DHA 10% 200mg + Panax Ginseng extract 90mg + Lycopene 10% 4mcg + Glutathione 50mg + Astaxanthin 8mg + L-Carnitine Tartrate 200mg + L-Arginine 250mg + Zince 17mg + Selenium 40mcg + Magnesium 100mg + Vitamin C 40mg + Vitamin A 1000 IU + Vitamin D3 400 IU + Vitamin B12 1mcg + Vitamin B1 1.40mg
Composition : Collagen Peptide Type-I 40mg + Sodium Hyaluronate 30mg + Chondroitin Sulfate Sodium 200mg + Vitamin C 12.5mg + L-Arginine 500mg
Composition : Coral Calcium 750mg Eq. to Calcium 225mg + Vitamin D3 500 IU Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cinacalcet 60mg Tablet has strong demand in the nephrology and endocrinology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for Cinacalcet 60mg Tablet in chronic kidney disease-related hyperparathyroidism. Including this product helps strengthen their specialty renal care portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cinacalcet 60mg Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, steady demand in the chronic kidney disease segment, timely product availability, and professional marketing support when partnering with Cafoli Lifecare for this formulation.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Cinacalcet 60mg Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.